CFB and ovarian carcinoma: Our cell viability CCK8 data demonstrated that if the ROR1-cFab concentration was equal or greater than 40μg/mL, ROR1-cFab treatment was able to efficiently reduce the viability of ROR1-positive ovarian cancer cells in a time-dependent manner.